Pneumonia vaccine response in individuals with Down syndrome at three specialty clinics

A clinical study found that 62% of individuals with Down syndrome had inadequate pneumococcal antibody responses to routine vaccination, despite standard immunization protocols. The researchers recommend serological screening of all individuals with Down syndrome using pneumococcal titers to assess vaccine effectiveness rather than relying on clinical predictors alone.